Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome.
about
High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestrySafety, Tolerability, and Immunogenicity of InterferonsMeta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cellsCentral role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.Genetic and pharmacologic inhibition of the Ca2+ influx channel TRPC3 protects secretory epithelia from Ca2+-dependent toxicity.Autophagy in autoimmune diseaseThe Role of Autophagy in Salivary Gland Homeostasis and Stress Responses.Macroautophagy is deregulated in murine and human lupus T lymphocytesAssessment of blood clot formation and platelet receptor function ex vivo in patients with primary Sjogren's syndrome.Dendritic cells in hepatitis C infection: can they (help) win the battle?Potential roles of nucleotide-binding oligomerization domain 2 in the pathogenesis of systemic lupus erythematosus.Plasma alpha-L-fucosidase activity in chronic inflammation and autoimmune disorders in a pediatric cohort of hospitalized patients.Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.Rapamycin has suppressive and stimulatory effects on human plasmacytoid dendritic cell functions.Epigallocatechin-3-gallate modulates antioxidant and DNA repair-related proteins in exocrine glands of a primary Sjogren's syndrome mouse model prior to disease onset.Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity.STS-1 promotes IFN-α induced autophagy by activating the JAK1-STAT1 signaling pathway in B cells.A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23
P2860
Q27316407-3827F49D-4166-407A-BD7A-6ADACE9F611FQ33435810-87FCF3B4-0862-4B09-8F08-606B499D84E9Q33915692-1D699519-DB87-41E8-80DC-3527C1051FFFQ34027578-6A85D488-9209-41A3-8C37-4511A12663EFQ35028058-CD3759F7-7870-4E44-B17C-D9620F59990EQ35800364-1EF2F1E6-5099-4058-8B1C-ED786876D5B9Q35932740-BC736164-062C-4437-98D2-1A4EC5FA5682Q36194783-ED21BCCA-3DC9-4BA8-8B8A-C2F1893CD787Q36889466-8A36D3C7-EA7C-482B-AF28-84646909CF5AQ37843841-18D848C7-42A1-41A6-9803-5DC49C68EEBDQ38193722-352FD65C-22E0-418C-AAA1-65EFCEED25F8Q38624584-5A717970-4A92-45A8-9548-F1D5094C230BQ40079471-80CC35E7-6448-4F59-933F-A8B4F2AB12E1Q45872926-74EEBF4E-D228-4827-A485-E3B4FF777AA7Q50492763-A2883E8F-0FBD-4DB3-A0D7-DF1918174CE3Q51401255-B111522C-A3A8-4999-93F8-94FC4859F09AQ54273025-8229AC9D-399F-4660-AF26-B1EFC12AB129Q57603213-AC2268E5-853D-45B4-A353-365317E31D1A
P2860
Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Emerging new pathways of patho ...... atosus and Sjogren's syndrome.
@ast
Emerging new pathways of patho ...... atosus and Sjogren's syndrome.
@en
type
label
Emerging new pathways of patho ...... atosus and Sjogren's syndrome.
@ast
Emerging new pathways of patho ...... atosus and Sjogren's syndrome.
@en
prefLabel
Emerging new pathways of patho ...... atosus and Sjogren's syndrome.
@ast
Emerging new pathways of patho ...... atosus and Sjogren's syndrome.
@en
P2860
P1476
Emerging new pathways of patho ...... matosus and Sjogren's syndrome
@en
P2093
Andras Perl
P2860
P304
P356
10.1097/BOR.0B013E32832EFE6B
P50
P577
2009-09-01T00:00:00Z